Duality Advisers, LP Zoetis Inc. Transaction History

Duality Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$165.67 - $199.94 $2.05 Million - $2.47 Million	12,359 Added 43.7%	40,641 $6.88 Million
Q4 2023 Feb 01, 2024	BUY	$151.44 - $200.09 $2.89 Million - $3.81 Million	19,054 Added 206.48%	28,282 $5.58 Million
Q3 2023 Nov 02, 2023	SELL	$167.14 - $192.77 $2.35 Million - $2.71 Million	-14,062 Reduced 60.38%	9,228 $1.61 Million
Q2 2023 Jul 31, 2023	BUY	$160.94 - $186.23 $3.75 Million - $4.34 Million	23,290 New	23,290 $4.01 Million
Q4 2022 Feb 07, 2023	BUY	$131.14 - $157.47 $4.68 Million - $5.62 Million	35,707 New	35,707 $5.23 Million
Q2 2022 Aug 08, 2022	SELL	$155.97 - $200.09 $1.51 Million - $1.94 Million	-9,695 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$181.39 - $234.03 $1.76 Million - $2.27 Million	9,695 New	9,695 $1.83 Million

1,956

409M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $78.4B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.